Paradromics Inc. became the latest company developing a brain-computer interface (BCI) system to implant its technology, ...

The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British ...

South Korea’s pharmaceutical exports rose nearly 18% quarter-on-quarter to reach $2.56 billion in the first quarter (Q1) this year, according to the Korea Health Industry Development Institute.

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by synaptic dysfunction, neuronal loss and the accumulation of amyloid plaques and neurofibrillary tangles, ...

Epimab Biotherapeutics Inc. licensed out a development-ready KLK2/CD3 bispecific T-cell engager (TCE) for advanced prostate ...

Privately held Beckley Psytech Ltd. is to be taken over by Atai Life Sciences in an all-share deal that values the U.K.

Biopharma’s nonprofit deal and grant activity continues to settle into a post-pandemic rhythm, with both showing a sustained ...

Recludix Pharma Inc. has nominated a lead development candidate, REX-8756, an oral, selective and reversible small-molecule ...

A research team led by consultant and orthopedic surgeon Glen Liau Zi Qiang from Alexandra Hospital in Singapore developed a ...

LIN28 is a family of RNA-binding proteins that regulate stem cell biology and pluripotency and are involved in oncogenesis ...

Radiopharm Theranostics Ltd. has reported preclinical data from studies with the Lu177-B7H3-monoclonal antibody (mAb) RV-01 ...

Amber Implants BV reported no device-related adverse events were seen in any of the patients fitted with its Vcfix spinal ...